Indolent B-cell Non-Hodgkin Lymphoma (iNHL)
1 clinical trials · Condition
◉ Watch Indolent B-cell Non-Hodgkin Lymphoma (iNHL)
| Record | Firm | Date |
|---|---|---|
| First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (NCT03625037) | Genmab | 2018-06-26 |
Track Indolent B-cell Non-Hodgkin Lymphoma (iNHL) automatically
Every clearance here is in the API, with alerts when new ones post.